Clinical Trials Directory

Trials / Completed

CompletedNCT05422898

Discussing COVID-19 Vaccines in Private Facebook Groups

Empathic Engagement With the COVID-19 Vaccine Hesitant in Private Facebook Groups

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
508 (actual)
Sponsor
George Washington University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

As the COVID-19 pandemic persists, a sizable proportion of the U.S. population remains unvaccinated and at high risk of death and serious illness from COVID-19. Vaccine hesitancy, fueled by the proliferation of vaccine misinformation on social media, is one factor contributing to lack of vaccination. Current attempts to overcome vaccine misinformation focus on correcting or debunking falsehoods. Although debunking strategies are important components to any public health campaign, communications must also address rationales for vaccine hesitancy that vary among individuals and communities, and directly address the gist of their concerns in an empathetic, non-judgmental manner. We will conduct a randomized controlled trial to test the effectiveness of empathic, relationship-building interactions relative to standard provision of information on social media to address COVID-19 vaccine hesitancy.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGist messages on COVID-19 vaccinationParticipants will receive gist-based messages on COVID-19 vaccines and have their concerns addressed by a group moderator
BEHAVIORALCOVID-19 vaccine informationParticipants will receive a link to the Facebook COVID-19 Information Center via a private Facebook Group

Timeline

Start date
2022-01-17
Primary completion
2022-04-04
Completion
2022-04-04
First posted
2022-06-21
Last updated
2022-06-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05422898. Inclusion in this directory is not an endorsement.